evoke semaglutide Novo Nordisk said Monday that an older oral version of its diabetes treatment, semaglutide, failed to meet its main goal in late-stage trials assessing whether it could slow cognitive decline in Alzheimer's Oxord study says Novo Nordisk's

This is a no-pressure conversation where we can get to know you, understand your goals, and determine if our compounded semaglutide program is the right fit for you.

The study discovered pharmacies granting access to controlled drugs to people under the legal age limit and NHS nurses prescribing to people with average BMIprompting a doctor to comment that the situation was almost like the Wild West. UK Health Secretary Wes Streeting responded to these findings, calling them deeply concerning and emphasizing that it is totally unacceptable for any retailer to prescribe them without the correct medical supervision and ID and age verification. Pharmacies can no longer rely on online forms and photos for verification to grant patients unrestricted access to these medications

doi:10.1016/S2213-8587(20)30074-7 This post was written by our team of health writers for informational purposes only and does not constitute medical advice

Our community, Blue Circle Diabetes Foundation along with several others across the globe have been advocating for the inclusion of rapid acting analogue insulins & GLP-1s to the WHO Essential Medicine List to make them more accessible & affordable for whoever needs them